The impact of prescriber experience and continuity on adverse drug reactions in hospitalized cancer patients

Yue Tang, Jingui Xie, Aizong Shen, Linlin Liu, Fei Zhai, Changfang Fu

Research output: Contribution to journalArticlepeer-review

Abstract

Cancer patients suffer severely from bodily damage due to malignant neoplasms and live a life of low quality, while the occurrence of adverse drug reactions (ADRs) worsens these conditions. Risk factors associated with ADRs have been long discussed in the literature, yet few studies considered prescriber-related risks. This study filled the gap by examining the ADR risk of prescriber-related factors from two dimensions: prescriber experience and prescriber continuity. We conducted a logistic regression analysis to investigate the effects. The data for analysis contained 34,474 inpatient admissions linked to 2,750,685 medication orders. We found that both experienced prescriber and prescriber continuity are related to lower ADR risk. Our results also revealed that the involvement of more experienced physicians in the prescribing process could mitigate the harmful effects of prescriber non-continuity on ADRs.

Original languageEnglish
Pages (from-to)89-100
Number of pages12
JournalIISE Transactions on Healthcare Systems Engineering
Volume12
Issue number2
DOIs
StatePublished - 2022

Keywords

  • Cancer inpatients
  • adverse drug reactions
  • healthcare continuity
  • physician experience

Fingerprint

Dive into the research topics of 'The impact of prescriber experience and continuity on adverse drug reactions in hospitalized cancer patients'. Together they form a unique fingerprint.

Cite this